ABOUT
Who we are
- 01 VISION
We are a passionate, multi-disciplinary team of biologists, AI scientists, and business enablers united by a shared vision: to harness the power of AI to create a new wave of transformative medicines.
Ailux is the AI-driven biologics discovery division of XtalPi, a global leader in AI- and robotics-powered drug and materials innovation. At Ailux, we foster an agile, collaborative, and entrepreneurial culture that achieves success at scale.
We began our journey by acknowledging the overinflated expectations surrounding AI in drug discovery. Since 2021, we have been focusing on uncovering real, value-added applications grounded in biological insight and engineering creativity. This pursuit has culminated in the development of a pragmatic, end-to-end discovery platform designed to generate differentiated therapeutics.
Backed by visionary leadership, seasoned advisors, and strategic partnerships, we are now approaching a key inflection point as a new wave of therapeutic candidates is nearing the clinic. We are proud of leading biologics innovation through global collaborations.
- 02 TEAM
100+
- Employees
2 : 1
- Biologists : AI scientists
3
- Countries
80+
- Antibody discovery and engineering projects
Ailux is the AI-driven biologics discovery division of XtalPi, a global leader in AI- and robotics-powered drug and materials innovation. At Ailux, we foster an agile, collaborative, and entrepreneurial culture that achieves success at scale.
- We began our journey by acknowledging the overinflated expectations surrounding AI in drug discovery. Since 2021, we have been focusing on uncovering real, value-added applications grounded in biological insight and engineering creativity. This pursuit has culminated in developing a pragmatic, end-to-end discovery platform designed to generate differentiated therapeutics.
- Backed by visionary leadership, seasoned advisors, and strategic partnerships, we are now approaching a key inflection point as a new wave of therapeutic candidates is nearing the clinic. We also partner with global pharma and leading biotech companies to drive biologics innovation, aiming to address unmet medical needs across different therapeutic areas.
- 02 TEAM
100+
- Employees
2 : 1
- Biologists : AI scientists
3
- Countries
80+
- Antibody discovery and engineering projects
- 03 JOURNEY
How we got here
-
• Wet-lab and AI setup concurrently
-
• Launched XtalFold
• Unveiled Ailux
-
• AI licensing with UCB
• Expanded drug discovery partnerships
-
• Stealth mode within XtalPi
-
• Platform evolution
-
• AI licensing with Johnson & Johnson
• Global drug discovery collaborations
-
• Advancing differentiated pipeline
- 04 CAREER
Working together toward our shared mission
